Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SHLS | FSLR |
|---|---|---|
| Price | $8.15 | $176.16 |
| Change today | ▼ 1.81% | ▲ 0.89% |
| Market cap | $1.37B | $18.93B |
| Return, 3 months | -18.8% | -22.6% |
| Return, year to date | -4.1% | -32.6% |
| Return, 1 year | -6.8% | -23.3% |
| P/E (TTM) | 42.9 | 10.9 |
| P/B | 2.2 | 1.8 |
| P/E percentile vs own 5y | – | 5th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -3.7% |
| Net profit growth (YoY) | – | +23.6% |
| Gross margin | – | 44.0% |
| Operating margin | – | 33.6% |
| Net margin | – | 32.5% |
| Return on equity | – | 18.5% |
| Analyst target vs. price | +41.7% | +57.8% |
| Analyst buy share | 70% | 80% |
| RSI (14) | 57 | 38 |
| 30-day volatility | 60.9% | 52.0% |
| Max drawdown, 1 year | -47.5% | -45.9% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
